Why This Was Flagged for You

Based on your VISIA Emerging Brown Spots score

A clinically guided program considered when VISIA indicates early disruption in pigment regulation and tissue protection within this category.

This category reflects how evenly pigment activity and tissue protection mechanisms are functioning in the periocular region — the external tissue environment surrounding the eyes. These systems are influenced by cumulative exposure, inflammatory signaling, and the skin’s ability to regulate cellular turnover and defense.

A lower score indicates early imbalance in how pigment is being regulated within this neighbouring system. While this assessment does not evaluate the eyes themselves, it can reflect shared biological stress affecting nearby tissues that rely on similar processes such as barrier protection, oxidative stress control, and regulated cellular response.

When pigment regulation becomes less controlled, surrounding tissues may be more vulnerable to environmental stressors. Over time, this can increase surface sensitivity and background inflammatory load in the periocular region. For patients managing dry eye symptoms, excess tissue stress in this area may contribute to discomfort or reactivity that feels persistent, even as other aspects of care improve.

Supporting pigment regulation and tissue protection helps reduce cumulative stress in the periocular environment and promotes a more resilient external setting for comfort and recovery. Any visible pigment changes are considered secondary indicators that these protective systems are stabilizing — not the primary goal of care.

Many Island Eyecare and Helix MedSpa treatments already support tissue protection indirectly by improving inflammation balance and recovery capacity. This program is considered only when review suggests that additional, targeted support may help reinforce these protective mechanisms.

If you’d like confirmation on whether your current care already addresses this area, our clinical team can review your plan with you.

Review This With Our Clinical Team

Our team can review your findings and confirm whether your current care fully addresses this program or if additional support may be needed.

How This Program Is Addressed

Confirm Your Current Plan Coverage

If you’re unsure whether your existing treatments already support this area, our clinical team can walk through it with you.

Learn More About This Program

The information below provides additional clinical context in FAQ format for patients who would like a deeper understanding of how this program works and when additional intervention may be required. Reviewing these questions is optional and not required to proceed with care.

Although this assessment does not examine the eyes themselves, it highlights how surrounding tissues respond to environmental and inflammatory stress. Reduced tissue protection or regulation can increase background sensitivity around the eyes, which may influence comfort.

Often, yes. Treatments that support inflammation balance, circulation, and tissue recovery frequently reinforce protective mechanisms indirectly. This program is considered only if a clear gap remains after reviewing your response to existing care.

Some patients notice improved comfort, reduced surface reactivity, and greater stability in the periocular environment. Any visible pigment changes are secondary indicators that protective systems are responding.

No. A flagged score identifies an area to review, not a requirement for treatment. Many patients do well with their current care alone, and additional support is recommended only when it is likely to improve overall tissue resilience.

Your existing dry eye care can continue as planned and still provide meaningful benefit. Choosing not to add this program may mean some background tissue stress remains, but it does not prevent you from progressing with your current treatment pathway.

Discuss This Result With Our Clinical Team

VISIA provides a detailed, system-level view all at once. Many patients find it helpful to review these findings with our clinical team so we can clarify what matters now, what is already being addressed, and what may not require action at this time.